TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Life Science A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,109,457
|
1,778,045
|
1,352,720 |
| Earnings before taxes |
142,757
|
82,441
|
68,960 |
| Total assets |
486,667
|
330,085
|
335,146 |
| Current assets |
484,308
|
325,657
|
328,855 |
| Current liabilities |
124,630
|
93,777
|
45,820 |
| Equity capital |
361,754
|
235,327
|
287,942 |
| - share capital |
3,018
|
2,833
|
2,684 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.3%
|
71.3%
|
85.9% |
| Turnover per employee |
301,351
|
254,006
|
193,246 |
| Profit as a percentage of turnover |
6.8%
|
4.6%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
388.6%
|
347.3%
|
717.7% |
| Return on equity (ROE) |
39.5%
|
35.0%
|
23.9% |
| Change turnover |
215,004
|
350,334
|
322,426 |
| Change turnover % |
11%
|
25%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.